Health Product Regulatory Authority of Ireland has issued EUGMP certificate to Concord Biotech’s unit II (Valthera facility) located at Dholka in Ahmedabad, Gujarat.
In May 2024, Saudi Food and Drug Authority had successfully completed inspection of Concord Biotech’s manufacturing unit II, (formulation facility), located at Valthera from May 14, 2024 to May 16, 2024.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.